Quarantined pneumonia (Severe Acute Respiratory Syndrome) - Symptoms, Causes, Treatment & Prevention

```html

Overview

Quarantined pneumonia, more formally known as Severe Acute Respiratory Syndrome (SARS), is a viral respiratory illness caused by the coronavirus SARS‑CoV. First identified in November 2002 in the Guangdong province of China, the disease spread to 26 countries in 2003, culminating in a worldwide health alert. Although the 2003 outbreak was contained, the term “quarantined pneumonia” is still used in some medical literature to emphasize the strict isolation measures required to prevent transmission.

SARS primarily affects the lower respiratory tract, leading to viral pneumonia that can progress rapidly to respiratory failure. While most cases occurred in adults, children are not immune and can develop milder disease. The overall case‑fatality rate (CFR) was approximately 9–10 %—significantly higher than that of seasonal influenza (CDC).

Since the original epidemic, sporadic laboratory‑confirmed cases have been reported, largely linked to zoonotic exposure or laboratory accidents. Worldwide, the cumulative number of reported SARS cases remains under 8,500, but the legacy of the outbreak informs current pandemic preparedness.

Symptoms

Symptoms usually appear 2–7 days after exposure (incubation period 2–14 days). The clinical picture can be divided into early and progressive phases.

• Fever – Often the first sign, >38 °C (100.4 °F), persistent.
• Chills & rigors – Accompanying the fever.
• Dry cough – Non‑productive, may become productive as disease progresses.
• Shortness of breath (dyspnea) – Typically worsens 5–7 days after onset.
• Sore throat – Mild to moderate irritation.
• Headache – Often described as “tight band‑like”.
• Myalgia (muscle aches) – Generalized body pain.
• Fatigue – Profound exhaustion not relieved by rest.
• Chest pain – May be pleuritic (sharp on breathing).
• Gastro‑intestinal symptoms – Nausea, vomiting, or diarrhea occur in ~20 % of patients.
• Loss of appetite – Common during the acute phase.

In severe cases, patients develop acute respiratory distress syndrome (ARDS), requiring mechanical ventilation, and may show signs of multi‑organ involvement (e.g., elevated liver enzymes, renal impairment).

Causes and Risk Factors

Cause

SARS is caused by the SARS‑CoV virus, a member of the betacoronavirus family. The virus likely originated in horseshoe bats and spread to humans after an intermediate host—most plausibly civet cats in live‑animal markets—facilitated close human‑animal contact (WHO, 2003).

Risk Factors

• Close contact with an infected person – Household members, health‑care workers, or anyone within 1 meter for prolonged periods.
• Travel to or residence in outbreak areas – Especially during the 2002‑2003 epidemic; for future risk, any region with active SARS cases.
• Occupational exposure – Laboratory staff working with SARS‑CoV or related coronaviruses.
• Pre‑existing chronic lung disease – COPD, asthma, or interstitial lung disease increase risk of severe outcomes.
• Immune suppression – HIV, transplant recipients, chemotherapy patients.
• Older age – Case fatality rises sharply in patients >60 years old (CDC).

Diagnosis

Because early symptoms mimic influenza and other viral pneumonias, a high index of suspicion is essential, especially when epidemiologic links exist.

Clinical Evaluation

• Detailed history (travel, exposure, symptom onset).
• Physical exam focusing on respiratory sounds (rales, wheezes) and oxygen saturation.

Laboratory Tests

• Real‑time reverse transcription polymerase chain reaction (RT‑PCR) – Detects viral RNA from nasopharyngeal swabs, sputum, or bronchial lavage. Sensitivity improves after day 5 of illness.
• Serology – Paired acute and convalescent sera demonstrating a four‑fold rise in anti‑SARS‑CoV IgG. Useful for retrospective diagnosis.
• Complete blood count (CBC) – Often shows leukopenia (low white blood cells) and lymphopenia.
• Inflammatory markers – Elevated CRP, ESR, and sometimes ferritin, reflecting systemic inflammation.

Imaging Studies

• Chest X‑ray – Early “ground‑glass” infiltrates, progressing to multifocal consolidation.
• High‑resolution CT (HRCT) – More sensitive; shows bilateral peripheral ground‑glass opacities and interlobular septal thickening.

Differential Diagnosis

Influenza, COVID‑19, MERS, other viral pneumonias, bacterial pneumonia, and atypical organisms (e.g., Mycoplasma) must be ruled out.

Treatment Options

There is no specific antiviral approved solely for SARS. Management focuses on supportive care, early isolation, and mitigation of complications.

Supportive Care

• Oxygen therapy – Nasal cannula or face mask to maintain SpO₂ ≥ 94 %.
• Mechanical ventilation – Indicated for ARDS; low tidal volume (6 mL/kg predicted body weight) and prone positioning improve outcomes.
• Fluid management – Conservative strategy to avoid pulmonary edema.
• Fever control – Acetaminophen is preferred; NSAIDs can be used if no contraindication.

Pharmacologic Therapies

• Corticosteroids – High‑dose pulse methylprednisolone was used during the 2003 outbreak, but data are mixed; current guidance recommends using steroids only for refractory ARDS or septic shock, per WHO recommendations.
• Broad‑spectrum antibiotics – Empiric coverage for bacterial superinfection until bacterial infection is excluded.
• Antiviral agents (investigational) – Ribavirin, lopinavir/ritonavir, and interferon‑β were trialed; limited evidence of benefit. Participation in a clinical trial is advised if available.
• Immunomodulators – Agents such as tocilizumab (IL‑6 receptor antagonist) are under investigation for cytokine storm mitigation.

Adjunctive Measures

• Thromboprophylaxis – Low‑molecular‑weight heparin to prevent venous thromboembolism, especially in immobilized patients.
• Nutrition – High‑protein, calorie‑dense diet; consider enteral feeding if oral intake is insufficient.
• Physical therapy – Early mobilization as tolerated to preserve muscle mass.

Living with Quarantined Pneumonia (Severe Acute Respiratory Syndrome)

Even after discharge, many survivors experience lingering effects. Below are practical tips for ongoing recovery.

Follow‑up Care

• Schedule a post‑discharge visit within 2 weeks for repeat chest imaging and pulmonary function testing.
• Monitor for persistent cough, dyspnea, or fatigue; report worsening to your provider.

Daily Management

• Breathing exercises – Diaphragmatic breathing and incentive spirometry help re‑expand alveoli.
• Gradual activity increase – Start with short walks; use the “talk test” to gauge intensity.
• Hydration – Aim for 2–3 L of fluids per day unless fluid‑restricted.
• Balanced diet – Emphasize fruits, vegetables, lean protein, and omega‑3 fatty acids to support immune recovery.
• Sleep hygiene – 7–9 hours of quality sleep each night to aid healing.
• Stress management – Mindfulness, gentle yoga, or counseling can help address post‑viral anxiety.

Psychosocial Support

Isolation during the acute phase can be traumatic. Consider joining a support group for SARS survivors or speaking with a mental‑health professional.

Prevention

Because SARS spreads primarily via respiratory droplets and close contact, classic infection‑control measures are effective.

• Hand hygiene – Wash hands with soap for ≥20 seconds or use an alcohol‑based sanitizer (>60 % ethanol).
• Respiratory etiquette – Cover coughs/sneezes with a tissue or elbow.
• Mask use – Surgical masks for patients; N95 respirators for health‑care workers during aerosol‑generating procedures.
• Isolation – Promptly isolate suspected cases in a single room with closed doors; use negative‑pressure rooms when available.
• Environmental cleaning – Disinfect high‑touch surfaces (doorknobs, phones) with EPA‑registered agents.
• Travel precautions – Review travel advisories, avoid live‑animal markets, and seek medical attention if symptoms develop after travel to affected regions.
• Vaccination research – While no licensed vaccine exists for SARS‑CoV, ongoing research on pan‑coronavirus vaccines may offer future protection (NIH, 2022).

Complications

If not promptly recognized and treated, SARS can lead to serious, sometimes fatal, complications:

• Acute Respiratory Distress Syndrome (ARDS) – Rapidly progressive hypoxemia requiring ventilatory support.
• Secondary bacterial pneumonia – Often caused by Staphylococcus aureus or Streptococcus pneumoniae.
• Septic shock – Multisystem organ failure due to an uncontrolled inflammatory response.
• Cardiovascular events – Myocarditis, arrhythmias, or acute coronary syndrome.
• Renal failure – Acute tubular necrosis secondary to hypoxia or nephrotoxic drugs.
• Long‑term pulmonary fibrosis – Persistent dyspnea and reduced lung volumes in up to 15 % of survivors (Cleveland Clinic, 2005).
• Neurologic sequelae – Encephalopathy, peripheral neuropathy, or post‑viral fatigue syndrome.

When to Seek Emergency Care

---

Sources: CDC – SARS Overview, WHO – SARS Fact Sheet, Mayo Clinic, NIH – Clinical Features, Cleveland Clinic.

```